A clinical trial of introduction and adjustment of insulin Degludec in hospitalized patients with type 2 diabetes
Not Applicable
- Conditions
- type 2 diabetes
- Registration Number
- JPRN-UMIN000035758
- Lead Sponsor
- Department of Diabetes and Endocrinology, Kansai Rosai Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 34
Inclusion Criteria
Not provided
Exclusion Criteria
1)The patient that an agreement to participate in this examination is not provided 2)The patient who needs emergency for treatment including the diabetic ketoacidosis 3)The patient whom diabetic retinopathy is unstable 4)The patient who uses insulin from before hospitalization
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The days before fasting blood glucose achieving aim blood sugar level (126 mg/dl or less), ratio less than 70 mg/dl of sensor glucose levels, hypoglycemia frequency.
- Secondary Outcome Measures
Name Time Method The hospitalization days, ratio of before less than 70-140 mg/dl of sensor glucose levels in the discharge day , correlation with the main end-point and patient background